Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kuojun Ren"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Anlotinib, an oral multitarget tyrosine kinase inhibitor, has shown the ability to inhibit tumor angiogenesis. This study aimed to assess the effectiveness and safety of anlotinib plus docetaxel, epirubicin, and cyclophosphamide (
Externí odkaz:
https://doaj.org/article/0e7222d947ac49879f57d2335069df4f
Publikováno v:
Cancer Research. 83:P2-01
background While neo-adjuvant anthracycline and taxane-based chemotherapy remains the standard of care for locally advanced TNBC, the optimal chemotherapy regimen is debatable. Anlotinib, a novel multi-target tyrosine kinase inhibitor that effectivel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68bbf4683a0d1361a54312b9d707b10c
https://doi.org/10.1158/1538-7445.sabcs22-p2-01-08
https://doi.org/10.1158/1538-7445.sabcs22-p2-01-08
Publikováno v:
Cancer Management and Research
Kuojun Ren,1,* Yachao Yin,2,* Fang He,3 Yi Shao,4 Shengying Wang1 1Department of Head–Neck and Breast Surgery, Anhui Provincial Cancer Hospital, The First Affiliated Hospital of The University of Science and Technology of China (USTC), Division of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47833fdc628cb69e37a67835522fbd1f
https://pubmed.ncbi.nlm.nih.gov/30425580
https://pubmed.ncbi.nlm.nih.gov/30425580
Publikováno v:
Zhonghua yi xue za zhi. 95(2)
To explore the apoptosis-inducing effect of Ad-p53 plus fulvestrant in MCF-7 breast cancer cells.ER-positive MCF-7 breast cancer cells were used. MCF-7 cells were established with control, fulvestrant alone, Ad-p53 alone and Ad-p53 plus fulvestrant.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f7a8ab3318a3559ddbd12c6b1bef1cd6
https://pubmed.ncbi.nlm.nih.gov/25876901
https://pubmed.ncbi.nlm.nih.gov/25876901